Shingles vaccine can be beneficial even when it doesn't ward off disease

A Kaiser Permanente study shows that the shingles vaccine can reduce the long-term pain of those who contracted the disease even though they were vaccinated. The study, published in The Journal of Infectious Diseases, demonstrated that these people had a lower risk of developing post-herpetic neuralgia (PHN), a potentially painful and long-lasting complication of shingles. More

Suggested Articles

With its phase 3 trial moving right along, Moderna is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else.

BioNTech expects a quick turnaround once the transaction closes and plans to produce up to 250 million doses of BNT162b2 in the first half of 2021.

Participation in clinical trials among Black people is low, FDA statistics show, even as drugmakers prioritize including them in COVID-19 shot trials.